Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00481039 |
|
Recruitment Status :
Completed
First Posted : June 1, 2007
Last Update Posted : September 4, 2009
|
Sponsor:
HaEmek Medical Center, Israel
Information provided by:
HaEmek Medical Center, Israel
| Tracking Information | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| First Submitted Date | May 31, 2007 | |||||||||
| First Posted Date | June 1, 2007 | |||||||||
| Last Update Posted Date | September 4, 2009 | |||||||||
| Study Start Date | May 2007 | |||||||||
| Actual Primary Completion Date | December 2008 (Final data collection date for primary outcome measure) | |||||||||
| Current Primary Outcome Measures | Not Provided | |||||||||
| Original Primary Outcome Measures | Not Provided | |||||||||
| Change History | ||||||||||
| Current Secondary Outcome Measures | Not Provided | |||||||||
| Original Secondary Outcome Measures | Not Provided | |||||||||
| Current Other Pre-specified Outcome Measures | Not Provided | |||||||||
| Original Other Pre-specified Outcome Measures | Not Provided | |||||||||
| Descriptive Information | ||||||||||
| Brief Title | Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel | |||||||||
| Official Title | Sickle Cell Anemia in an Arab Bedouin Village in the Northern Israel- An Observational Study | |||||||||
| Brief Summary | Sickle cell anemia and sickle cell thalassemia are frequent diseases among the israeli arab population. The purpose of this study is to assess the clinical characteristics of the patients in one arab village and the laboratory characteristics in the carriers of this gene based in the screening for pregnant women that is carried out in the population of northern Israel. The results can be useful in order to institute universal screening for sickle cell anemia in northern Israel. |
|||||||||
| Detailed Description | Not Provided | |||||||||
| Study Type | Observational | |||||||||
| Study Design | Observational Model: Case-Only Time Perspective: Retrospective |
|||||||||
| Target Follow-Up Duration | Not Provided | |||||||||
| Biospecimen | Not Provided | |||||||||
| Sampling Method | Non-Probability Sample | |||||||||
| Study Population | All the patients diagnosed with abnormal hemoglobin in the bedouin arab village | |||||||||
| Condition | Sickle Cell Disease | |||||||||
| Intervention | Procedure: Medical history and basic laboratory analysis
Medical history and basic laboratory analysis
|
|||||||||
| Study Groups/Cohorts | 1
Patients diagnosed as having abnormal hemoglobin like hemoglobin S and thalassemia in a bedouin village
Intervention: Procedure: Medical history and basic laboratory analysis
|
|||||||||
| Publications * | Not Provided | |||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
||||||||||
| Recruitment Information | ||||||||||
| Recruitment Status | Completed | |||||||||
| Estimated Enrollment |
300 | |||||||||
| Original Enrollment | Not Provided | |||||||||
| Actual Study Completion Date | December 2008 | |||||||||
| Actual Primary Completion Date | December 2008 (Final data collection date for primary outcome measure) | |||||||||
| Eligibility Criteria | Inclusion Criteria:
|
|||||||||
| Sex/Gender |
|
|||||||||
| Ages | Child, Adult, Older Adult | |||||||||
| Accepts Healthy Volunteers | No | |||||||||
| Contacts | Contact information is only displayed when the study is recruiting subjects | |||||||||
| Listed Location Countries | Israel | |||||||||
| Removed Location Countries | ||||||||||
| Administrative Information | ||||||||||
| NCT Number | NCT00481039 | |||||||||
| Other Study ID Numbers | 5311006.EMC | |||||||||
| Has Data Monitoring Committee | No | |||||||||
| U.S. FDA-regulated Product | Not Provided | |||||||||
| IPD Sharing Statement | Not Provided | |||||||||
| Current Responsible Party | Dr Koren Ariel, Pediatric Hematology Unit - Ha'Emek Medical Center | |||||||||
| Original Responsible Party | Not Provided | |||||||||
| Current Study Sponsor | HaEmek Medical Center, Israel | |||||||||
| Original Study Sponsor | Same as current | |||||||||
| Collaborators | Not Provided | |||||||||
| Investigators |
|
|||||||||
| PRS Account | HaEmek Medical Center, Israel | |||||||||
| Verification Date | September 2009 | |||||||||